Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 461


18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer.

Wieder H, Beer AJ, Siveke J, Schuster T, Buck AK, Herrmann K, Stollfuss JC.

Oncotarget. 2018 Jan 12;9(11):10128-10134. doi: 10.18632/oncotarget.24176. eCollection 2018 Feb 9.


Inflammatory responses and inflammation-associated diseases in organs.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L.

Oncotarget. 2017 Dec 14;9(6):7204-7218. doi: 10.18632/oncotarget.23208. eCollection 2018 Jan 23. Review.


Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma.

Zielinska E, Zauszkiewicz-Pawlak A, Wojcik M, Inkielewicz-Stepniak I.

Oncotarget. 2017 Nov 20;9(4):4675-4697. doi: 10.18632/oncotarget.22563. eCollection 2018 Jan 12.


Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.

Zhang J, Liu C, Mo X, Shi H, Li S.

Oncol Lett. 2018 Feb;15(2):1771-1776. doi: 10.3892/ol.2017.7512. Epub 2017 Dec 5.


The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.

Kadhim LA, Dholakia AS, Herman JM, Wahl RL, Chaudhry MA.

J Radiat Oncol. 2013 Dec;2(4):341-352. doi: 10.1007/s13566-013-0130-7. Epub 2013 Oct 30.


Nomogram for predicting survival in patients with pancreatic cancer.

Song W, Miao DL, Chen L.

Onco Targets Ther. 2018 Jan 24;11:539-545. doi: 10.2147/OTT.S154599. eCollection 2018.


Patient-derived organoid models help define personalized management of gastrointestinal cancer.

Aberle MR, Burkhart RA, Tiriac H, Olde Damink SWM, Dejong CHC, Tuveson DA, van Dam RM.

Br J Surg. 2018 Jan;105(2):e48-e60. doi: 10.1002/bjs.10726. Review.


MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.

Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang J, He S, Hu W, Liu X.

Oncotarget. 2017 Nov 18;8(64):107500-107512. doi: 10.18632/oncotarget.22494. eCollection 2017 Dec 8.


Detection of K-ras gene mutations in feces by magnetic nanoprobe in patients with pancreatic cancer: A preliminary study.

Wang X, Wang J, Chen F, Zhong Z, Qi L.

Exp Ther Med. 2018 Jan;15(1):527-531. doi: 10.3892/etm.2017.5368. Epub 2017 Oct 24.


Gemcitabine treatment causes resistance and malignancy of pancreatic cancer stem-like cells via induction of lncRNA HOTAIR.

Wang L, Dong P, Wang W, Huang M, Tian B.

Exp Ther Med. 2017 Nov;14(5):4773-4780. doi: 10.3892/etm.2017.5151. Epub 2017 Sep 20.


Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery.

Petrella F, Rimoldi I, Rizzo S, Spaggiari L.

Medicines (Basel). 2017 Nov 23;4(4). pii: E87. doi: 10.3390/medicines4040087. Review.


Tumors of the Pancreatic Body and Tail.

Barreto SG, Shukla PJ, Shrikhande SV.

World J Oncol. 2010 Apr;1(2):52-65. doi: 10.4021/wjon2010.04.200w. Epub 2010 Apr 30. Review.


A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.

Liu X, Zheng W, Wang W, Shen H, Liu L, Lou W, Wang X, Yang P.

Br J Cancer. 2017 Dec 5;117(12):1846-1854. doi: 10.1038/bjc.2017.365. Epub 2017 Nov 9. Erratum in: Br J Cancer. 2018 Feb 13;:.


Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.

Kumar S, Inigo JR, Kumar R, Chaudhary AK, O'Malley J, Balachandar S, Wang J, Attwood K, Yadav N, Hochwald S, Wang X, Chandra D.

Cancer Lett. 2018 Jan 28;413:82-93. doi: 10.1016/j.canlet.2017.10.029. Epub 2017 Oct 26.


Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.

Jawad ZAR, Theodorou IG, Jiao LR, Xie F.

Sci Rep. 2017 Oct 30;7(1):14309. doi: 10.1038/s41598-017-14688-z.


Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.

Zhang YJ, Wen CL, Qin YX, Tang XM, Shi MM, Shen BY, Fang Y.

Oncol Rep. 2017 Dec;38(6):3335-3346. doi: 10.3892/or.2017.6026. Epub 2017 Oct 12.


Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.

Lee J, Lee J, Yun JH, Choi C, Cho S, Kim SJ, Kim JH.

Sci Rep. 2017 Oct 6;7(1):12760. doi: 10.1038/s41598-017-13023-w.


Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.

Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C.

J Cell Mol Med. 2018 Jan;22(1):655-667. doi: 10.1111/jcmm.13351. Epub 2017 Oct 5.


Unresectable Pancreatic Adenocarcinoma: Eight Years Later.

Smiley K, Malhotra R, Peche W, Langell JT.

World J Oncol. 2016 Feb;7(1):17-20. doi: 10.14740/wjon957w. Epub 2016 Apr 3.

Supplemental Content

Support Center